CHICAGO – Former Inteliquet CEO Carla Balch has quietly launched a new venture, Spesana, which is developing a visualization-based clinical decision support tool to help medical practitioners make sense of molecular diagnostics tests and the massive amounts of data that accompany the test results.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.